Monday, May 06, 2019 3:31:43 PM
............that if there are day traders in here they will make a mistake if they sell. This stock has strong management . They all left lucrative positions to come here and it is not like their options were initially unfairly priced.
I think and agree with the research put on the board clearly shows the driver on here may have to do with endometreosis and infertility which affects over 27 million women in united states alone.
We know we already have the trademark on the endometreosis test. There are some Pfizer people on the board. i do not want to speculate but in my opinion anyone thinking of selling a $4 or $5 would be making a mistake when this stock has the potential to be a min boggling number. Just my opinion, but they say management is A+ and the CEO although someone said he has 40 million shares, in my opinion did not put this all together to sell the stock a $4 or $5. Alleyba thinks we are in for a nice ride
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM